XML 43 R32.htm IDEA: XBRL DOCUMENT
v3.22.4

Stock-Based Compensation (Tables) | 9 Months Ended
--- | ---
Dec. 31, 2022
Share-based Payment Arrangement, Noncash Expense [Abstract] |
Schedule of Repurchase Agreements | The following table summarizes total shares repurchased during the three and nine months ended December 31, 2022 and 2021:
| November 2020 Program |  | August 2022 Program |  | Total |  |  |  |
(In millions) | Shares |  | Amount |  | Shares |  | Amount |  | Shares |  | Amount |  |  |  |  |  |  |  |
Three months ended December 31, 2022 | — |  |  | $ | 5 |  |  | 2.6 |  |  | $ | 320 |  |  | 2.6 |  |  | $ | 325 |  |  |  |  |  |  |  |  |
Nine months ended December 31, 2022 | 5.1 |  | $ | 650 |  |  | 2.6 |  |  | $ | 320 |  |  | 7.7 |  |  | $ | 970 |  |  |  |  |  |  |  |  |
Three months ended December 31, 2021 | 2.4 |  | $ | 325 |  |  | — |  |  | $ | — |  |  | 2.4 |  |  | $ | 325 |  |  |  |  |  |  |  |  |
Nine months ended December 31, 2021 | 7.0 |  | $ | 975 |  |  | — |  |  | $ | — |  |  | 7.0 |  |  | $ | 975 |  |  |  |  |  |  |  |  |
Disclosure Of Stock-Based Compensation Arrangements By Stock-Based Payment Award | The following table summarizes our stock option activity for the nine months ended December 31, 2022:
|  | Options (in thousands) |  | Weighted- Average Exercise Prices |  | Weighted- Average Remaining Contractual Term (in years) |  | Aggregate Intrinsic Value (in millions)
Outstanding as of March 31, 2022 |  | 286 |  |  | $ | 39.28 |  |  |  |  |
Granted |  | 2 |  |  | 125.55 |  |  |  |  |
Exercised |  | (164) |  |  | 39.47 |  |  |  |  |
Forfeited, cancelled or expired |  | (1) |  |  | 64.95 |  |  |  |  |
Outstanding as of December 31, 2022 |  | 123 |  |  | $ | 40.69 |  |  | 2.21 |  | $ | 10 |
Vested and expected to vest |  | 123 |  |  | $ | 40.69 |  |  | 2.21 |  | $ | 10 |
Exercisable as of December 31, 2022 |  | 122 |  |  | $ | 40.04 |  |  | 2.16 |  | $ | 10 |
The following table summarizes our restricted stock units activity for the nine months ended December 31, 2022:
| Restricted Stock Units (in thousands) |  | Weighted- Average Grant Date Fair Values
Outstanding as of March 31, 2022 | 6,682 |  |  | $ | 129.57 |
Granted | 4,970 |  |  | 127.44 |
Vested | (3,332) |  |  | 126.20 |
Forfeited or cancelled | (695) |  |  | 131.78 |
Outstanding as of December 31, 2022 | 7,625 |  |  | $ | 129.45 |
The following table summarizes our performance-based restricted stock unit activity, presented with the maximum number of shares that could potentially vest, for the nine months ended December 31, 2022:
| Performance- Based Restricted Stock Units (in thousands) |  | Weighted- Average Grant Date Fair Value
Outstanding as of March 31, 2022 | 190 |  |  | $ | 142.60 |
Granted | 509 |  |  | 127.98 |
Vested | (73) |  |  | 142.60 |
Forfeited or cancelled | (69) |  |  | 136.28 |
Outstanding as of December 31, 2022 | 557 |  |  | $ | 130.03 |
The following table summarizes our market-based restricted stock unit activity, presented with the maximum number of shares that could potentially vest, for the nine months ended December 31, 2022:
| Market-Based Restricted Stock Units (in thousands) |  | Weighted- Average Grant Date Fair Value
Outstanding as of March 31, 2022 | 1,321 |  |  | $ | 134.69 |
Granted | 178 |  |  | 176.70 |
Vested | (95) |  |  | 114.97 |
Forfeited or cancelled | (582) |  |  | 129.16 |
Outstanding as of December 31, 2022 | 822 |  |  | $ | 149.98 |
The following table summarizes stock-based compensation expense resulting from stock options, restricted stock units, market-based restricted stock units, performance-based restricted stock units, and the ESPP purchase rights included in our Condensed Consolidated Statements of Operations (in millions):
| Three Months Ended December 31, |  | Nine Months Ended December 31,
| 2022 |  | 2021 |  | 2022 |  | 2021
Cost of revenue | $ | 2 |  |  | $ | 1 |  |  | $ | 5 |  |  | $ | 4 |
Research and development | 95 |  |  | 86 |  |  | 271 |  |  | 272 |
Marketing and sales | 15 |  |  | 14 |  |  | 44 |  |  | 41 |
General and administrative | 29 |  |  | 28 |  |  | 86 |  |  | 86 |
Stock-based compensation expense | $ | 141 |  |  | $ | 129 |  |  | $ | 406 |  |  | $ | 403 |

X
- Definition Tabular disclosure of share-based payment arrangement. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 718 -SubTopic 10 -Section 50 -Paragraph 1 -URI http://asc.fasb.org/extlink&oid=120381028&loc=d3e5047-113901 Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 718 -SubTopic 10 -Section 50 -Paragraph 2 -URI http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901 + Details
Name: | us-gaap_DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition The entire disclosure for repurchase agreements. + References No definition available. + Details
Name: | us-gaap_ScheduleOfRepurchaseAgreements
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | us-gaap_ShareBasedCompensationAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration